Hormone replacement therapy and the breast
- 15 December 2001
- Vol. 323 (7326), 1381-1382
- https://doi.org/10.1136/bmj.323.7326.1381
Abstract
Increasing numbers of women in their 50s and 60s are using hormone replacement therapy to alleviate menopausal symptoms. The effect of long term use of these agents in women aged over 50 on the breast is only now becoming apparent. Hormone replacement therapy given to perimenopausal women increases breast pain and nodularity, increases the frequency of benign cysts and fibroadenomas in the breast, and results in the growth of some already established benign lesions.1 Breast density increases in 17% to 73% of women who use hormone replacement therapy depending on how breast density is assessed. No clear relation exists between duration of therapy and change in density on mammography. Combinations of oestrogen and progestogen increase breast density more than oestrogen alone. Continuous use of combined preparations of oestrogen and progestogen increase density more than their sequential use.2 Hormone replacement therapy affects both the sensitivity and specificity of breast screening. This is because the efficacy of breast screening depends on the decreasing breast density seen with age. In a recent study of 103 770 women from Australia …This publication has 13 references indexed in Scilit:
- Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study: A Prospective, Observational StudyAnnals of Internal Medicine, 2001
- Postmenopausal hormone therapy for prevention of fractures: how good is the evidence?Jama-Journal Of The American Medical Association, 2001
- More about: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.JNCI Journal of the National Cancer Institute, 2000
- Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus ProgestinJNCI Journal of the National Cancer Institute, 2000
- Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer RiskJama-Journal Of The American Medical Association, 2000
- Hormone replacement therapy and accuracy of mammographic screeningThe Lancet, 2000
- Risks of breast and endometrial cancer after estrogen and estrogen–progestin replacementCancer Causes & Control, 1999
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal WomenNew England Journal of Medicine, 1995
- Enlarging occult fibroadenomas.Radiology, 1992